Eurogin roadmap 2017: triage strategies for the management of HPV‐positive women in cervical screening programs
Cervical cancer screening will rely, increasingly, on HPV testing as a primary screen. The
requirement for triage tests which can delineate clinically significant infection is thus …
requirement for triage tests which can delineate clinically significant infection is thus …
[HTML][HTML] Choosing wisely in oncology: necessity and obstacles
P Saletti, P Sanna, L Gabutti, M Ghielmini - Esmo Open, 2018 - Elsevier
In the last decades, the survival of many patients with cancer improved thanks to modern
diagnostic methods and progresses in therapy. Still for several tumours, especially when …
diagnostic methods and progresses in therapy. Still for several tumours, especially when …
[HTML][HTML] Factors associated with low adherence to cervical cancer follow-up retest among HPV+/cytology negative women: a study in programmatic context in a low …
J Gago, M Paolino, S Arrossi - BMC cancer, 2019 - Springer
Abstract Background Cervical Cancer is still a major public health challenge in low and
middle-income countries. HPV testing has been an innovative approach, which was …
middle-income countries. HPV testing has been an innovative approach, which was …
Eight‐type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV‐positive women
R Rezhake, SY Hu, S Zhao, XQ Xu… - … journal of cancer, 2019 - Wiley Online Library
The management of HPV‐positive women becomes particularly crucial in cervical cancer
screening. Here we assessed whether detection of E6 or E7 oncoproteins targeting eight …
screening. Here we assessed whether detection of E6 or E7 oncoproteins targeting eight …
Acceptability of self-sampling for human papillomavirus-based cervical cancer screening
K Chatzistamatiou, T Vrekoussis… - Journal of women's …, 2020 - liebertpub.com
Background: Human papillomavirus (HPV)-DNA testing combined with self-sampling could
increase cervical cancer screening effectiveness, utilizing a sensitive screening modality …
increase cervical cancer screening effectiveness, utilizing a sensitive screening modality …
[HTML][HTML] Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden
S Fogelberg, MS Clements, K Pedersen, S Sy… - PloS one, 2020 - journals.plos.org
Background Sweden revised their cervical cancer screening program in 2017 to include
cytology-based screening for women aged 23–29 years and primary human papillomavirus …
cytology-based screening for women aged 23–29 years and primary human papillomavirus …
Switching clinic‐based cervical cancer screening programs to human papillomavirus self‐sampling: A cost‐effectiveness analysis of vaccinated and unvaccinated …
Several countries have implemented primary human papillomavirus (HPV) testing for
cervical cancer screening. HPV testing enables home‐based, self‐collected sampling (self …
cervical cancer screening. HPV testing enables home‐based, self‐collected sampling (self …
Reducing overtreatment associated with overdiagnosis in cervical cancer screening—A model‐based benefit–harm analysis for Austria
G Sroczynski, E Esteban… - … journal of cancer, 2020 - Wiley Online Library
A general concern exists that cervical cancer screening using human papillomavirus (HPV)
testing may lead to considerable overtreatment. We evaluated the trade‐off between …
testing may lead to considerable overtreatment. We evaluated the trade‐off between …
Cost‐effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model‐based analysis
A Portnoy, K Pedersen, S Sy, A Tropé… - … Journal of Cancer, 2024 - Wiley Online Library
As Norway considers revising triage approaches following their first adolescent cohort with
human papillomavirus (HPV) vaccination entering the cervical cancer screening program …
human papillomavirus (HPV) vaccination entering the cervical cancer screening program …
Acceleration of cervical cancer diagnosis with human papillomavirus testing below age 30: Observational study
M Rebolj, CS Mathews, F Pesola… - … Journal of Cancer, 2022 - Wiley Online Library
Several international cervical screening guidelines advise against using high‐risk human
papillomavirus (HR‐HPV) testing in women younger than 30. The rationale for this in young …
papillomavirus (HR‐HPV) testing in women younger than 30. The rationale for this in young …